应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
08622 愉悦集团
国庆日休市 09-30 16:08:25
0.160
-0.011
-6.43%
最高
0.168
最低
0.154
成交量
92.80万
今开
0.168
昨收
0.171
日振幅
8.19%
总市值
8,240万
流通市值
8,240万
总股本
5.15亿
成交额
14.67万
换手率
0.18%
流通股本
5.15亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
愉悦集团(08622):独立非执行董事郑发丁遭会财局公开谴责并罚款35万港元 董事会称不影响公司运作
公告速递 · 09-15
愉悦集团(08622):独立非执行董事郑发丁遭会财局公开谴责并罚款35万港元 董事会称不影响公司运作
愉悦集团2015年度购股权调整:注销合共4,504,000份,行使价每股0.125港元
公告速递 · 09-09
愉悦集团2015年度购股权调整:注销合共4,504,000份,行使价每股0.125港元
愉悦集团更新8月股份变动月报表,股本维持稳定
公告速递 · 09-01
愉悦集团更新8月股份变动月报表,股本维持稳定
愉悦集团(08622)公布最新董事会及委员会构成
公告速递 · 08-31
愉悦集团(08622)公布最新董事会及委员会构成
愉悦集团(08622.HK):郑发丁获委任为独立非执行董事及审核委员会主席
智通财经 · 08-31
愉悦集团(08622.HK):郑发丁获委任为独立非执行董事及审核委员会主席
愉悦集团(08622)发布中期业绩 期内亏损242.8万元 同比扩大2.49%
智通财经 · 08-29
愉悦集团(08622)发布中期业绩 期内亏损242.8万元 同比扩大2.49%
愉悦集团2026年上半年营收1655.70万元,同比增长34.3%
公告速递 · 08-28
愉悦集团2026年上半年营收1655.70万元,同比增长34.3%
愉悦集团2026年中期财报营收约1656万元
公告速递 · 08-28
愉悦集团2026年中期财报营收约1656万元
华康生物医学(08622)拟于8月28日召开董事会审议2026年中期业绩
公告速递 · 08-18
华康生物医学(08622)拟于8月28日召开董事会审议2026年中期业绩
华康生物医学2026年7月股份变动月报:股本保持稳定
公告速递 · 08-03
华康生物医学2026年7月股份变动月报:股本保持稳定
华康生物医学6月股份变动月报表:股本维持不变
公告速递 · 07-02
华康生物医学6月股份变动月报表:股本维持不变
华康生物医学5月无新增发行或股份变动
公告速递 · 06-01
华康生物医学5月无新增发行或股份变动
华康生物医学拟回购最多10%股份
公告速递 · 05-29
华康生物医学拟回购最多10%股份
华康生物医学更新4月股份变动月报表,股本维持稳定
公告速递 · 05-04
华康生物医学更新4月股份变动月报表,股本维持稳定
华康生物医学盘中异动 股价大涨6.25%
市场透视 · 2025-03-06
华康生物医学盘中异动 股价大涨6.25%
华康生物医学(08622):施美伶辞任独立非执行董事
智通财经 · 2025-02-28
华康生物医学(08622):施美伶辞任独立非执行董事
华康生物医学盘中异动 股价大涨6.06%
市场透视 · 2025-02-27
华康生物医学盘中异动 股价大涨6.06%
华康生物医学盘中异动 早盘大幅下挫5.97%
市场透视 · 2025-02-26
华康生物医学盘中异动 早盘大幅下挫5.97%
华康生物医学盘中异动 大幅拉升6.06%报0.350港元
市场透视 · 2025-02-25
华康生物医学盘中异动 大幅拉升6.06%报0.350港元
华康生物医学盘中异动 早盘股价大跌7.25%报0.320港元
市场透视 · 2025-02-24
华康生物医学盘中异动 早盘股价大跌7.25%报0.320港元
加载更多
公司概况
公司名称:
愉悦集团
所属市场:
SEHK
上市日期:
--
主营业务:
愉悦集团有限公司(原名:华康生物医学控股有限公司)是一家主要从事生产及销售生物制剂及辅助生育用品业务的投资控股公司。该公司通过两个分部营运业务。生物制剂及辅助生育用品及设备分部主要从事生产及销售男性不育体外诊断试剂产品。健康产品及保健品分部主要从事销售健康产品。
发行价格:
--
{"stockData":{"symbol":"08622","market":"HK","secType":"STK","nameCN":"愉悦集团","latestPrice":0.16,"timestamp":1790755705766,"preClose":0.171,"halted":0,"volume":928000,"delay":0,"changeRate":-0.06432748538011701,"floatShares":515000000,"shares":515000000,"eps":-0.011677665392854622,"marketStatus":"国庆日休市","change":-0.011,"latestTime":"09-30 16:08:25","open":0.168,"high":0.168,"low":0.154,"amount":146728,"amplitude":0.081871,"askPrice":0.166,"askSize":8000,"bidPrice":0.157,"bidSize":40000,"shortable":0,"etf":0,"ttmEps":-0.011649638995911772,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790904600000},"marketStatusCode":7,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":0.171,"openAndCloseTimeList":[[1790731800000,1790740800000],[1790744400000,1790755200000]],"volumeRatio":3.295454546741832,"lotSize":8000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/08622","defaultTab":"news","newsList":[{"id":"1173396239","title":"愉悦集团(08622):独立非执行董事郑发丁遭会财局公开谴责并罚款35万港元 董事会称不影响公司运作","url":"https://stock-news.laohu8.com/highlight/detail?id=1173396239","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173396239?lang=zh_cn&edition=full","pubTime":"2026-09-15 18:32","pubTimestamp":1789468348,"startTime":"0","endTime":"0","summary":"愉悦集团有限公司9月15日公告称,董事会接获独立非执行董事郑发丁博士的通知,香港会计及财务汇报局(会财局)已于2026年9月10日发布新闻稿,对郑博士及加多利会计师事务所有限公司作出公开谴责,并向郑博士处以35万港元罚款。截至公告日,愉悦集团董事会由执行董事周训勇博士、张玉静女士、张春光先生及潘礼贤先生;非执行董事卜素博士;独立非执行董事周国辉博士、王亚纯女士及郑发丁博士组成。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137265208","title":"愉悦集团2015年度购股权调整:注销合共4,504,000份,行使价每股0.125港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137265208","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137265208?lang=zh_cn&edition=full","pubTime":"2026-09-09 18:36","pubTimestamp":1788950209,"startTime":"0","endTime":"0","summary":"愉悦集团(股票代码:08622)披露的信息显示,于截至2015年12月31日止年度内,该公司已注销合共4,504,000份购股权,此等购股权的行使价格为每股0.125港元。同期,公司就上述获授且尚未行权的购股权,其行使前的股份加权平均收市价为每股0.431港元。该期间内并无进一步提及关于其他股份类别或投票权结构的变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"愉悦集团2015年度购股权调整:注销合共4,504,000份,行使价每股0.125港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109565206","title":"愉悦集团更新8月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1109565206","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109565206?lang=zh_cn&edition=full","pubTime":"2026-09-01 15:22","pubTimestamp":1788247361,"startTime":"0","endTime":"0","summary":"愉悦集团有限公司于2026年9月1日发布截至2026年8月31日的股份变动月报表。报告显示,公司在本报告期内股本结构及已发行股数保持稳定。截至8月底,公司已发行股份数为515,472,000股,库藏股为0股,股份总数较上月底无变化。本月未有新增发行、购回、注销或库藏股份变动,同时公司无股份期权、权证、可换股票据及其他任何导致股本变动的安排。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169146070","title":"愉悦集团(08622)公布最新董事会及委员会构成","url":"https://stock-news.laohu8.com/highlight/detail?id=1169146070","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169146070?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:35","pubTimestamp":1788176150,"startTime":"0","endTime":"0","summary":"2026年8月31日,愉悦集团公告披露最新董事会成员及其角色、职能,并同步更新三大董事委员会人员名单。公告采用「C」代表委员会主席、「M」代表委员会成员,各人员职能已在上述列表中对应标示。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663645070","title":"愉悦集团(08622.HK):郑发丁获委任为独立非执行董事及审核委员会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2663645070","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663645070?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:30","pubTimestamp":1788175806,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["08622","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663247090","title":"愉悦集团(08622)发布中期业绩 期内亏损242.8万元 同比扩大2.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663247090","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663247090?lang=zh_cn&edition=full","pubTime":"2026-08-29 01:25","pubTimestamp":1787937919,"startTime":"0","endTime":"0","summary":"智通财经APP讯,愉悦集团(08622)发布截至2026年6月30日止6个月业绩,该集团期内取得收入1655.7万元人民币,同比增加34.29%;期内亏损242.8万元,同比扩大2.49%;每股基本亏损0.47仙。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488879.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176732123","title":"愉悦集团2026年上半年营收1655.70万元,同比增长34.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1176732123","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176732123?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:58","pubTimestamp":1787921898,"startTime":"0","endTime":"0","summary":"愉悦集团公布2026年上半年财报,期内实现营收1655.70万元,同比增长34.3%。公司报告期内毛利为1056万元,同比增加25.5%,毛利率从68.3%下降至63.8%。管理层在财报中指出,毛利率下滑主要由于新增健康产品及保健品业务毛利率较相对较低所致。报告期内,销售及分销费用约410万元,同比增长15.5%;占营收比重约为24.70%。财报显示,生物制剂及辅助生育用品和设备板块在2026年上半年实现营收1298.90万元,同比增长5.4%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"愉悦集团2026年上半年营收1655.70万元,同比增长34.3%","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162995080","title":"愉悦集团2026年中期财报营收约1656万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162995080","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162995080?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:46","pubTimestamp":1787921214,"startTime":"0","endTime":"0","summary":"愉悦集团披露,截至2026年6月30日止六个月,实现营收约1656万元,同比增长34.3%。本期毛利率为63.8%,相比上一年同期的68.3%有所下降。经营活动产生的净现金流为流出约480万元。生物制剂及辅助生育用品和设备板块上半年实现营收约1300万元,同比增长5.4%。其中核心男性不育体外诊断试剂销售额约1040万元,保持稳健增长。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"愉悦集团2026年中期财报营收约1656万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123256903","title":"华康生物医学(08622)拟于8月28日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1123256903","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1123256903?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:36","pubTimestamp":1787045764,"startTime":"0","endTime":"0","summary":"华康生物医学8月18日公告称,公司董事会将于2026年8月28日(星期五)召开会议,主要议程包括:。公告显示,公司现任董事会成员包括:执行董事张玉静女士、周训勇博士、张春光先生及潘礼贤先生;非执行董事卜素博士;独立非执行董事周国辉博士、王亚纯女士及徐永得先生。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144627267","title":"华康生物医学2026年7月股份变动月报:股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1144627267","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144627267?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:33","pubTimestamp":1785749603,"startTime":"0","endTime":"0","summary":"华康生物医学于2026年8月3日发布2026年7月股份变动月报表。报告显示,公司本月的注册股本无变动,法定/注册股本仍为10,000,000港元,其中普通股的法定/注册股数维持为1,000,000,000股,每股面值0.01港元。截至2026年7月31日,华康生物医学已发行普通股股份总数约为515,472,000股,与上月底保持一致,库存股份数量仍为零。公司表示,截至2026年7月31日,已符合香港联合交易所有限公司就公众持股量的有关规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151179713","title":"华康生物医学6月股份变动月报表:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1151179713","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151179713?lang=zh_cn&edition=full","pubTime":"2026-07-02 20:48","pubTimestamp":1782996488,"startTime":"0","endTime":"0","summary":"华康生物医学(08622)于2026年7月2日公布截至2026年6月30日的月报表。报告显示,公司法定注册股本为1,000,000,000股,面值每股0.01港元,合计10,000,000港元,与上个月并无变动。\n截至2026年6月30日,公司已发行普通股股数为515,472,000股,未持有任何库藏股,本月既无新增发行股份,也无回购或注销活动。公司本月未有股权激励计划、可换股债券及其他权益性工具的变动情况。\n公司声明已遵循香港联交所《上市规则》及其他相关法律法规。截至本月末,公司股本和公众持股量符合相关规定。公告由公司秘书周丽麒签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183125536","title":"华康生物医学5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1183125536","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183125536?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:01","pubTimestamp":1780304466,"startTime":"0","endTime":"0","summary":"华康生物医学于2026年6月1日发布截至2026年5月31日的月报表。公告显示,公司在报告期内未进行任何新增股份发行、股份购回或注销,也无库藏股变动。本次月报显示,华康生物医学截至2026年5月31日的注册股本维持在1,000,000,000股普通股,每股面值为港币0.01元,注册股本总额为港币10,000,000元。报告指出,公司于当月并无股份期权或股权激励计划相关的新增、行使或失效,也未发生可换股票据或其他协议下的股份发行活动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158714691","title":"华康生物医学拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1158714691","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158714691?lang=zh_cn&edition=full","pubTime":"2026-05-29 20:36","pubTimestamp":1780058163,"startTime":"0","endTime":"0","summary":"华康生物医学发布公告,董事会拟于即将召开的股东周年大会上寻求授予股份购回授权,规模最高可达公司已发行股份总数的10%,折合约5,154.72万股。该公司目前总发行股份数为5.15472亿股。公告显示,本次购回资金将按照华康生物医学的组织章程大纲、公司细则及开曼群岛法律等适用规则从合法来源支出。华康生物医学已将上述议案列入定于2026年6月26日举行的股东周年大会进行表决。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华康生物医学拟回购最多10%股份","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143412991","title":"华康生物医学更新4月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143412991","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143412991?lang=zh_cn&edition=full","pubTime":"2026-05-04 19:16","pubTimestamp":1777893381,"startTime":"0","endTime":"0","summary":"华康生物医学(08622)于2026年5月4日发布截至2026年4月30日的股份变动月报表。报告显示,公司于本月未有新增股份发行或回购活动,股本结构维持不变。\n根据公告,截至2026年4月底,公司法定股本维持在1,000,000,000股,面值为每股0.01港元,注册股本总额为约1,000万港元。普通股的已发行股份总数为515,472,000股,与上月底持平,未发生增减变动,库销股数量仍为0股。\n报告同时确认公司已符合适用的公众持股量要求,并在本月严格遵守香港联合交易所有限公司《上市规则》及所有相关法律法规。公告由公司秘书周丽麒签署。公司表示将继续按照合规要求进行后续信息披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517189066","title":"华康生物医学盘中异动 股价大涨6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517189066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517189066?lang=zh_cn&edition=full","pubTime":"2025-03-06 15:20","pubTimestamp":1741245634,"startTime":"0","endTime":"0","summary":"2025年03月06日下午盘15时20分,华康生物医学股票出现异动,股价急速拉升6.25%。截至发稿,该股报0.340港元/股,成交量32万股,换手率0.06%,振幅9.38%。华康生物医学股票所在的生物技术行业中,整体涨幅为0.49%。华康生物医学公司简介:本集团是一家专注于在中国研发、生产及销售各种体外诊断试剂及辅助生育用品和设备的医疗器械集团。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306152034a261ffc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306152034a261ffc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08622","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514328193","title":"华康生物医学(08622):施美伶辞任独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2514328193","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514328193?lang=zh_cn&edition=full","pubTime":"2025-02-28 19:47","pubTimestamp":1740743252,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华康生物医学(08622)发布公告,施美伶为投放更多时间在其个人业务和其他事务,故而辞任公司独立非执行董事,自2025年2月28日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1256405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514420819","title":"华康生物医学盘中异动 股价大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514420819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514420819?lang=zh_cn&edition=full","pubTime":"2025-02-27 09:56","pubTimestamp":1740621367,"startTime":"0","endTime":"0","summary":"2025年02月27日早盘09时56分,华康生物医学股票出现异动,股价急速上涨6.06%。截至发稿,该股报0.350港元/股,成交量1.6万股,换手率0.00%,振幅6.06%。华康生物医学股票所在的生物技术行业中,整体涨幅为0.19%。华康生物医学公司简介:本集团是一家专注于在中国研发、生产及销售各种体外诊断试剂及辅助生育用品和设备的医疗器械集团。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270956079631dcc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270956079631dcc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08622","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514076340","title":"华康生物医学盘中异动 早盘大幅下挫5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514076340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514076340?lang=zh_cn&edition=full","pubTime":"2025-02-26 11:04","pubTimestamp":1740539061,"startTime":"0","endTime":"0","summary":"2025年02月26日早盘11时04分,华康生物医学股票出现波动,股价快速下挫5.97%。截至发稿,该股报0.315港元/股,成交量25.6万股,换手率0.05%,振幅2.99%。华康生物医学股票所在的生物技术行业中,整体涨幅为1.08%。华康生物医学公司简介:本集团是一家专注于在中国研发、生产及销售各种体外诊断试剂及辅助生育用品和设备的医疗器械集团。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226110421963097c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226110421963097c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1222","08622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514081104","title":"华康生物医学盘中异动 大幅拉升6.06%报0.350港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514081104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514081104?lang=zh_cn&edition=full","pubTime":"2025-02-25 09:33","pubTimestamp":1740447203,"startTime":"0","endTime":"0","summary":"2025年02月25日早盘09时33分,华康生物医学股票出现波动,股价大幅拉升6.06%。截至发稿,该股报0.350港元/股,成交量8000股,换手率0.00%,振幅0.00%。资金方面,该股资金流入2800港元,流出0港元。华康生物医学股票所在的生物技术行业中,整体跌幅为1.82%。其相关个股中,科笛-B、华康生物医学、正大企业国际涨幅较大,振幅较大的相关个股有药明巨诺-B、科笛-B、腾盛博药-B,振幅分别为9.91%、7.98%、6.54%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093323962f2835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225093323962f2835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08622","BK1222"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513959817","title":"华康生物医学盘中异动 早盘股价大跌7.25%报0.320港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513959817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513959817?lang=zh_cn&edition=full","pubTime":"2025-02-24 10:30","pubTimestamp":1740364251,"startTime":"0","endTime":"0","summary":"2025年02月24日早盘10时30分,华康生物医学股票出现波动,股价急速下跌7.25%。截至发稿,该股报0.320港元/股,成交量3.2万股,换手率0.01%,振幅7.25%。资金方面,该股资金流入8280港元,流出2560港元。华康生物医学股票所在的生物技术行业中,整体跌幅为1.95%。华康生物医学公司简介:本集团是一家专注于在中国研发、生产及销售各种体外诊断试剂及辅助生育用品和设备的医疗器械集团。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224103051962de12f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224103051962de12f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["08622","BK1222"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.szhuakang.com","stockEarnings":[{"period":"1week","weight":-0.1489},{"period":"1month","weight":-0.1304},{"period":"3month","weight":-0.2},{"period":"6month","weight":-0.5362},{"period":"1year","weight":-0.6},{"period":"ytd","weight":-0.6322}],"compareEarnings":[{"period":"1week","weight":-0.0089},{"period":"1month","weight":-0.0373},{"period":"3month","weight":0.0676},{"period":"6month","weight":-0.02},{"period":"1year","weight":-0.0835},{"period":"ytd","weight":-0.0397}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"愉悦集团有限公司(原名:华康生物医学控股有限公司)是一家主要从事生产及销售生物制剂及辅助生育用品业务的投资控股公司。该公司通过两个分部营运业务。生物制剂及辅助生育用品及设备分部主要从事生产及销售男性不育体外诊断试剂产品。健康产品及保健品分部主要从事销售健康产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.26126},{"month":2,"riseRate":0.25,"avgChangeRate":-0.073213},{"month":3,"riseRate":0,"avgChangeRate":-0.097699},{"month":4,"riseRate":0.625,"avgChangeRate":0.012289},{"month":5,"riseRate":0.375,"avgChangeRate":-0.035893},{"month":6,"riseRate":0.375,"avgChangeRate":-0.006127},{"month":7,"riseRate":0.375,"avgChangeRate":0.030316},{"month":8,"riseRate":0.625,"avgChangeRate":0.0551},{"month":9,"riseRate":0.5,"avgChangeRate":-0.006484},{"month":10,"riseRate":0.428571,"avgChangeRate":0.028155},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.032964},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.042176}],"exchange":"SEHK","name":"愉悦集团","nameEN":"JOYZYME GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"愉悦集团(08622)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供愉悦集团(08622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"愉悦集团,08622,愉悦集团股票,愉悦集团股票老虎,愉悦集团股票老虎国际,愉悦集团行情,愉悦集团股票行情,愉悦集团股价,愉悦集团股市,愉悦集团股票价格,愉悦集团股票交易,愉悦集团股票购买,愉悦集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"愉悦集团(08622)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供愉悦集团(08622)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}